Lincoln Pharmaceuticals Limited announced earnings results for the third quarter ended December 31, 2020. For the third quarter, the company announced total revenue was INR 1,154.763 Million compared to INR 1,015.586 Million a year ago. Net income was INR 134.818 Million compared to INR 109.109 Million a year ago. Basic earnings per share from continuing operations was INR 6.74 compared to INR 5.46 a year ago. For the nine months, total revenue was INR 3,477.34 Million compared to INR 3,148.764 Million a year ago. Net income was INR 496.511 Million compared to INR 424.948 Million a year ago. Basic earnings per share from continuing operations was INR 24.83 compared to INR 21.25 a year ago.